Zhejiang Medicine Co.,Ltd. (600216.SH) disclosed its 2025 semi-annual report. During the reporting period, the company achieved revenue of 4.323 billion yuan, down 1.87% year-on-year; net profit attributable to parent company reached 673 million yuan, up 113.52% year-on-year; adjusted net profit was 665 million yuan, up 110.10% year-on-year; basic earnings per share stood at 0.70 yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments